Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Immune Checkpoint Inhibitor Outcomes for Patients With Non–Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications

PaperCitations, authors & open-access status

Immune Checkpoint Inhibitor Outcomes for Patients With Non–Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 327 citations, 2019 year and closed oa status.

327
Citations
2019
Year
closed
OA Status

Related on ScholarIQ

Biagio Ricciuti
Author
Lynette M. Sholl
Author
Mizuki Nishino
Author
Journal of Clinical Oncology
Journal
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
470M+ articles · free account